DREAM Activators
DREAM activators, as listed here, are primarily chemicals that influence calcium signaling or neuronal activity, which can indirectly affect DREAM's function. These compounds do not directly interact with DREAM but modulate the cellular environment and pathways critical to DREAM's roles. Calcium channel blockers such as Nimodipine, Isradipine, Nifedipine, Amlodipine, and Verapamil influence intracellular calcium levels, which are crucial for the activation and function of DREAM. DREAM is known to be calcium-sensitive, and changes in calcium dynamics could therefore modulate its activity.
Agents like Dantrolene and Ryanodine, which affect calcium release from the sarcoplasmic reticulum, and Thapsigargin, an ER calcium pump inhibitor, also play a role in modulating calcium homeostasis, potentially impacting DREAM activity. Caffeine and BAPTA-AM represent different mechanisms of influencing calcium signaling, with caffeine affecting calcium release channels and BAPTA-AM being a calcium chelator. These compounds might indirectly alter DREAM function through changes in calcium signaling. Neuroactive substances like Tetrodotoxin, which blocks sodium channels, and Gabapentin, which affects calcium channels, could influence neuronal activity and indirectly modulate DREAM function, given DREAM's involvement in neuronal processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Nimodipine | 66085-59-4 | sc-201464 sc-201464A | 100 mg 1 g | $60.00 $301.00 | 2 | |
Nimodipine, a calcium channel blocker, could indirectly affect DREAM by altering intracellular calcium levels, which are crucial for DREAM's function. | ||||||
Isradipine | 75695-93-1 | sc-201467 sc-201467A | 10 mg 50 mg | $86.00 $318.00 | 1 | |
Isradipine, another calcium channel blocker, may modulate calcium signaling pathways, potentially impacting DREAM activity. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $58.00 $170.00 | 15 | |
Nifedipine, used to influence calcium dynamics in cells, could indirectly affect DREAM's role in calcium-dependent processes. | ||||||
Amlodipine | 88150-42-9 | sc-200195 sc-200195A | 100 mg 1 g | $73.00 $163.00 | 2 | |
Amlodipine, by modulating calcium influx, could indirectly influence DREAM activity related to calcium signaling. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
Verapamil, a calcium channel antagonist, might impact DREAM function by altering calcium homeostasis in neurons. | ||||||
Dantrolene | 7261-97-4 | sc-500165 | 25 mg | $350.00 | 7 | |
Dantrolene interferes with calcium release from the sarcoplasmic reticulum and may indirectly influence DREAM's calcium-dependent activities. | ||||||
Ryanodine | 15662-33-6 | sc-201523 sc-201523A | 1 mg 5 mg | $219.00 $765.00 | 19 | |
Ryanodine, by modulating calcium release from the sarcoplasmic reticulum, could indirectly affect DREAM function. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 5 g 100 g 250 g 1 kg 5 kg | $32.00 $66.00 $95.00 $188.00 $760.00 | 13 | |
Caffeine, which influences calcium signaling by affecting calcium release channels, could have an indirect effect on DREAM. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin, an ER calcium pump inhibitor, might influence DREAM activity by altering calcium homeostasis. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $449.00 | 61 | |
BAPTA-AM, a calcium chelator, could indirectly affect DREAM by modulating intracellular calcium levels. | ||||||